Skip to main content

Finasteride News

Treatment of Lower Urinary Tract Symptoms Tied to Reduced Risk for Death in Men

FRIDAY, Sept. 15, 2023 – For men with lower urinary tract symptoms, treatment is associated with a reduced risk for death, according to a study published in the Oct. 1 issue of The Journal of...

FDA Approves Entadfi (finasteride and tadalafil) as a New Treatment for Benign Prostatic Hyperplasia

MIAMI, Dec. 13, 2021 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of breast and prostate cancer, a...

FDA Medwatch Alert: MasterPharm, LLC. Issues Voluntary Nationwide Recall of Finasteride Plus 1.25mg Due to the Presence of an Undeclared Antihypertensive Drug

May 11, 2020 – MasterPharm, LLC. is voluntarily recalling 1 lot of Finasteride Plus 1.25mg, capsules to the consumer level. The Finasteride Plus capsules have been found to contain undeclared...

FDA Medwatch Alert: 5-alpha reductase inhibitors (5-ARIs): Label Change - Increased Risk of Prostate Cancer

Drugs in the 5-ARI class include finasteride and dutasteride. These drugs are marketed under the brand-names Proscar, Propecia, Avodart, and Jalyn ISSUE: FDA notified healthcare professionals that...

FDA Medwatch Alert: Citalopram And Finasteride by Greenstone: Recall - Possible Mislabeling

ISSUE: Greenstone LLC announced a recall of medicines with lot number FI0510058-A on the label. Bottles labeled as Citalopram (used to treat depression) may contain Finasteride (used for the...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Benign Prostatic Hyperplasia (BPH)

Finasteride patient information at Drugs.com